This announcement is a separate document:
シンバイオ製薬：末梢性T細胞リンパ腫（PTCL）に対するブリンシドフォビルの抗腫瘍効果を確認 がん原遺伝子MYCの抑制及び免疫調整遺伝子の発現を誘導
SymBio Pharmaceuticals: Confirmed antitumor effect of brentuximab vedotin on peripheral T-cell lymphoma (PTCL), inducing suppression of oncogene MYC and expression of immune regulatory genes.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.